海达舍画阁药业有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
8
NMPA:8
Drug Approvals
Memantine Hydrochloride Oral Solution
- Product Name
- 盐酸美金刚口服溶液
- Approval Number
- 国药准字H20183420
- Approval Date
- Nov 27, 2023
NMPA
Atomoxetine Hydrochloride Oral Solution
- Product Name
- 盐酸托莫西汀口服溶液
- Approval Number
- 国药准字H20234055
- Approval Date
- Aug 29, 2023
NMPA
Lacosamide Oral Solution
- Product Name
- 拉考沙胺口服溶液
- Approval Number
- 国药准字H20234028
- Approval Date
- Aug 8, 2023
NMPA
Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution
- Product Name
- 氨溴特罗口服溶液
- Approval Number
- 国药准字H20183185
- Approval Date
- Jun 6, 2023
NMPA
Levetiracetam Oral Solution
- Product Name
- 左乙拉西坦口服溶液
- Approval Number
- 国药准字H20213334
- Approval Date
- May 11, 2021
NMPA
Clinical Trials
No trials found
News
No news found